{"id":447,"date":"2026-08-27T10:31:11","date_gmt":"2026-08-27T10:31:11","guid":{"rendered":"https:\/\/nhdbio.com\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/ja\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/","title":{"rendered":"Tirzepatide \u30c7\u30e5\u30a2\u30eb GIP\/GLP-1 \u30b7\u30b0\u30ca\u30ea\u30f3\u30b0: \u30e1\u30ab\u30cb\u30ba\u30e0\u3068\u30c8\u30e9\u30a4\u30a2\u30eb \u30a8\u30f3\u30c9\u30dd\u30a4\u30f3\u30c8\u306e\u8aac\u660e"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">Tirzepatide \u306f\u3001\u30b0\u30eb\u30b3\u30fc\u30b9\u4f9d\u5b58\u6027\u30a4\u30f3\u30b9\u30ea\u30f3\u5206\u6ccc\u6027\u30dd\u30ea\u30da\u30d7\u30c1\u30c9 (GIP) \u53d7\u5bb9\u4f53\u3068\u30b0\u30eb\u30ab\u30b4\u30f3\u69d8\u30da\u30d7\u30c1\u30c9 1 (GLP-1) \u53d7\u5bb9\u4f53\u306e\u4e21\u65b9\u3092\u6d3b\u6027\u5316\u3059\u308b\u3088\u3046\u306b\u8a2d\u8a08\u3055\u308c\u305f\u30a2\u30b7\u30eb\u5316\u30da\u30d7\u30c1\u30c9\u3067\u3059\u3002\u4e8c\u91cd\u85ac\u7406\u5b66\u3092\u7406\u89e3\u3059\u308b\u306b\u306f\u3001\u7279\u5b9a\u306e\u96c6\u56e3\u3067\u6e2c\u5b9a\u3055\u308c\u305f\u81e8\u5e8a\u7d50\u679c\u304b\u3089\u53d7\u5bb9\u4f53\u6d3b\u6027\u3092\u5206\u96e2\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">\u91cd\u8981\u306a\u30dd\u30a4\u30f3\u30c8<\/h2><ul class=\"wp-block-list\"><li>Tirzepatide \u306f\u3001\u300c\u30c8\u30ea\u30d7\u30eb \u30a2\u30b4\u30cb\u30b9\u30c8\u300d\u3067\u306f\u306a\u304f\u3001\u30c7\u30e5\u30a2\u30eb GIP\/GLP-1 \u53d7\u5bb9\u4f53\u30a2\u30b4\u30cb\u30b9\u30c8\u3067\u3059\u3002<\/li><li>SURPASS \u8a66\u9a13\u306f\u30012 \u578b\u7cd6\u5c3f\u75c5\u306e\u8ee2\u5e30\u306b\u7126\u70b9\u3092\u5f53\u3066\u307e\u3057\u305f\u3002 SURMOUNT \u8a66\u9a13\u306f\u3001\u80a5\u6e80\u95a2\u9023\u306e\u7d50\u679c\u306b\u7126\u70b9\u3092\u5f53\u3066\u307e\u3057\u305f\u3002<\/li><li>FDA \u304c\u627f\u8a8d\u3057\u305f\u6700\u7d42\u533b\u85ac\u54c1\u30c7\u30fc\u30bf\u306f\u3001\u7121\u95a2\u4fc2\u306a\u7814\u7a76\u7528\u9014\u306e\u30ab\u30bf\u30ed\u30b0\u8cc7\u6599\u306e\u54c1\u8cea\u3001\u5b89\u5168\u6027\u3001\u6709\u52b9\u6027\u3092\u78ba\u7acb\u3059\u308b\u3082\u306e\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1672\" height=\"941\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research.png\" alt=\"\u5206\u5b50\u751f\u7269\u5b66\u7814\u7a76\u5ba4\u3067 3 \u3064\u306e\u30da\u30d7\u30c1\u30c9\u53d7\u5bb9\u4f53\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u7d4c\u8def\u3092\u691c\u8a0e\u3059\u308b\u7814\u7a76\u8005\" class=\"wp-image-442\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research.png 1672w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research-300x169.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research-1024x576.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research-768x432.png 768w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/metabolic-peptide-receptor-research-1536x864.png 1536w\" sizes=\"auto, (max-width: 1672px) 100vw, 1672px\" \/><figcaption class=\"wp-element-caption\">\u30de\u30eb\u30c1\u30ec\u30bb\u30d7\u30bf\u30fc\u30da\u30d7\u30c1\u30c9\u7814\u7a76\u306e\u30aa\u30ea\u30b8\u30ca\u30eb\u306e\u30a8\u30c7\u30a3\u30c8\u30ea\u30a2\u30eb\u30a4\u30e9\u30b9\u30c8\u3002\u3053\u308c\u306f\u6982\u5ff5\u7684\u306a\u5b9f\u9a13\u5ba4\u306e\u98a8\u666f\u3067\u3042\u308a\u3001\u88fd\u54c1\u3084\u6cbb\u7642\u306e\u753b\u50cf\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/figcaption><\/figure><h2 class=\"wp-block-heading\">\u4e8c\u91cd\u53d7\u5bb9\u4f53\u4f5c\u52d5\u6027\u306e\u610f\u5473<\/h2><p class=\"wp-block-paragraph\">GIP \u3068 GLP-1 \u306f\u3001\u91cd\u8907\u3059\u308b\u7570\u306a\u308b\u4f5c\u7528\u3092\u6301\u3064\u6804\u990a\u7d20\u5fdc\u7b54\u6027\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u30b7\u30b9\u30c6\u30e0\u3067\u3059\u3002 Tirzepatide \u306f\u3001\u4e21\u65b9\u306e\u53d7\u5bb9\u4f53\u3092\u6d3b\u6027\u5316\u3067\u304d\u308b 1 \u3064\u306e\u5206\u5b50\u3068\u3057\u3066\u8a2d\u8a08\u3055\u308c\u307e\u3057\u305f\u3002\u81e8\u5e8a\u52b9\u679c\u306f\u3001\u5206\u5b50\u5168\u4f53\u306e\u85ac\u7406\u3001\u66dd\u9732\u3001\u51e6\u65b9\u306e\u7d50\u679c\u3067\u3059\u3002 2 \u3064\u306e\u5225\u500b\u306e\u7d4c\u8def\u306e\u8aac\u660e\u3092\u5358\u7d14\u306b\u52a0\u7b97\u3059\u308b\u3060\u3051\u3067\u306f\u63a8\u8ad6\u3067\u304d\u307e\u305b\u3093\u3002<\/p><p class=\"wp-block-paragraph\">FDA \u30e9\u30d9\u30eb\u306f\u3001\u627f\u8a8d\u3055\u308c\u305f\u51e6\u65b9\u7b8b\u88fd\u54c1\u306e\u6709\u52b9\u6210\u5206\u3068\u3057\u3066\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9\u3092\u7279\u5b9a\u3057\u3001\u88fd\u54c1\u56fa\u6709\u306e\u9069\u5fdc\u75c7\u3001\u8b66\u544a\u3001\u51e6\u65b9\u306e\u8a73\u7d30\u3092\u8aac\u660e\u3057\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u8a18\u8ff0\u306f\u3001\u30e9\u30d9\u30eb\u306b\u8a18\u8f09\u3055\u308c\u3066\u3044\u308b\u627f\u8a8d\u6e08\u307f\u306e\u5b8c\u6210\u85ac\u306b\u5c5e\u3057\u307e\u3059\u3002<\/p><h2 class=\"wp-block-heading\">\u4f53\u9a13\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u898b\u65b9<\/h2><p class=\"wp-block-paragraph\">SURPASS-1 \u306f\u3001\u98df\u4e8b\u3068\u904b\u52d5\u306b\u3088\u308b\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u304c\u4e0d\u5341\u5206\u306a 2 \u578b\u7cd6\u5c3f\u75c5\u306e\u6210\u4eba\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30e9\u30f3\u30c0\u30e0\u5316\u76f8 3 \u8a66\u9a13\u3067\u3057\u305f\u3002\u305d\u306e\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u306f\u7cd6\u5316\u30d8\u30e2\u30b0\u30ed\u30d3\u30f3\u306e\u5909\u5316\u3067\u3042\u308a\u3001\u8ffd\u52a0\u306e\u7d50\u679c\u306b\u306f\u4f53\u91cd\u3068\u5b89\u5168\u6027\u304c\u542b\u307e\u308c\u3066\u3044\u305f\u3002 SURMOUNT-1 \u306f\u3001\u80a5\u6e80\u307e\u305f\u306f\u904e\u4f53\u91cd\u306b\u52a0\u3048\u3001\u4f53\u91cd\u95a2\u9023\u75be\u60a3\u3092\u6709\u3059\u308b\u6210\u4eba\u3092\u767b\u9332\u3057\u3001\u4f53\u91cd\u306e\u5909\u5316\u7387\u3092\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u3068\u3057\u3066\u4f7f\u7528\u3057\u307e\u3057\u305f\u3002<\/p><p class=\"wp-block-paragraph\">\u6bcd\u96c6\u56e3\u3001\u6bd4\u8f03\u5bfe\u8c61\u3001\u6cbb\u7642\u671f\u9593\u3001\u63a8\u5b9a\u5024\u3001\u304a\u3088\u3073\u4e2d\u6b62\u306e\u6271\u3044\u306f\u89e3\u91c8\u306b\u5f71\u97ff\u3057\u307e\u3059\u3002\u898b\u51fa\u3057\u306e\u30d1\u30fc\u30bb\u30f3\u30c6\u30fc\u30b8\u3092\u3053\u308c\u3089\u306e\u30c7\u30b6\u30a4\u30f3\u8981\u7d20\u304b\u3089\u5207\u308a\u96e2\u3057\u3066\u306f\u306a\u308a\u307e\u305b\u3093\u3002<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>SURPASS-1<\/strong><span>3\u76f8\u30012\u578b\u7cd6\u5c3f\u75c5\u3001\u8840\u7cd6\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee<\/span><\/div><div class=\"pim-evidence-row\"><strong>SURMOUNT-1<\/strong><span>3 \u76f8\u3001\u80a5\u6e80\/\u904e\u4f53\u91cd\u4eba\u53e3\u3001\u4f53\u91cd\u4e3b\u8981\u30a8\u30f3\u30c9\u30dd\u30a4\u30f3\u30c8<\/span><\/div><div class=\"pim-evidence-row\"><strong>\u898f\u5236\u8a18\u9332<\/strong><span>\u88fd\u54c1\u56fa\u6709\u306e FDA \u51e6\u65b9\u60c5\u5831\u3068\u5b89\u5168\u6027\u306b\u95a2\u3059\u308b\u6587\u8a00<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">\u7269\u8cea\u7684\u540c\u7b49\u6027\u304c\u91cd\u8981\u306a\u7406\u7531<\/h2><p class=\"wp-block-paragraph\">\u81e8\u5e8a\u8a66\u9a13\u306e\u7d50\u679c\u306f\u3001\u305d\u306e\u8a66\u9a13\u306e\u6761\u4ef6\u4e0b\u3067\u88fd\u9020\u304a\u3088\u3073\u7ba1\u7406\u3055\u308c\u305f\u7814\u7a76\u5bfe\u8c61\u306e\u4ecb\u5165\u306b\u9069\u7528\u3055\u308c\u307e\u3059\u3002\u914d\u5217\u540c\u4e00\u6027\u3060\u3051\u3067\u306f\u3001\u7d14\u5ea6\u3001\u51dd\u96c6\u3001\u5bfe\u30a4\u30aa\u30f3\u3001\u7121\u83cc\u6027\u3001\u5fae\u7c92\u5b50\u8ca0\u8377\u3001\u88fd\u5264\u307e\u305f\u306f\u5b89\u5b9a\u6027\u306b\u304a\u3051\u308b\u540c\u7b49\u6027\u3092\u8a3c\u660e\u3059\u308b\u3082\u306e\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p><p class=\"wp-block-paragraph\">\u30ab\u30bf\u30ed\u30b0\u306e\u8abf\u67fb\u8cc7\u6599\u306b\u3064\u3044\u3066\u306f\u3001\u7814\u7a76\u8005\u306f\u88fd\u54c1\u56fa\u6709\u306e\u4ed5\u69d8\u3068\u30ed\u30c3\u30c8\u306e\u6587\u66f8\u3092\u4fe1\u983c\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002\u627f\u8a8d\u3055\u308c\u305f\u533b\u85ac\u54c1\u306e\u81e8\u5e8a\u4e0a\u306e\u4e3b\u5f35\u3092\u7814\u7a76\u7528\u306e\u88fd\u54c1\u30da\u30fc\u30b8\u306b\u8ee2\u9001\u3059\u3079\u304d\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9\u4e8c\u91cd\u53d7\u5bb9\u4f53\u30a2\u30b4\u30cb\u30ba\u30e0\u3068\u3001SURPASS \u8a66\u9a13\u304a\u3088\u3073 SURMOUNT \u8a66\u9a13\u3067\u6e2c\u5b9a\u3055\u308c\u305f\u30a8\u30f3\u30c9\u30dd\u30a4\u30f3\u30c8\u306b\u3064\u3044\u3066\u306e\u8a3c\u62e0\u306b\u57fa\u3065\u3044\u305f\u8aac\u660e\u3002\u30ab\u30bf\u30ed\u30b0\u8cc7\u6599\u3078\u306e\u533b\u85ac\u54c1\u30c7\u30fc\u30bf\u306e\u9069\u7528\u306b\u306f\u660e\u78ba\u306a\u5236\u9650\u304c\u3042\u308a\u307e\u3059\u3002<\/p>","protected":false},"author":1,"featured_media":617,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"370","pim_article_type":"Clinical evidence explainer","pim_evidence_level":"Randomized phase 3 trials and FDA labeling","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-27","pim_editorial_note":"Source-checked against the linked primary or authoritative records on 2026-08-27. This is an evidence summary, not independent peer review, medical advice or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"SURPASS-1 randomized phase 3 trial\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34186022\/\",\"note\":\"Primary clinical trial record; PMID 34186022.\"},{\"title\":\"SURMOUNT-1 obesity trial\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35658024\/\",\"note\":\"Primary clinical trial record; PMID 35658024.\"},{\"title\":\"FDA prescribing information for Mounjaro (tirzepatide)\",\"url\":\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/215866s039lbl.pdf\",\"note\":\"Approved-finished-product regulatory record.\"}]","footnotes":""},"categories":[18],"tags":[],"class_list":["post-447","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-reviews"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Tirzepatide Dual GIP\/GLP-1 Signaling: Mechanism and Trial Endpoints Explained - NHD<\/title>\n<meta name=\"description\" content=\"An evidence-led explanation of tirzepatide dual receptor agonism and the endpoints measured in SURPASS and SURMOUNT trials, with clear limits on applying drug data to catalog materials.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/ja\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tirzepatide Dual GIP\/GLP-1 Signaling: Mechanism and Trial Endpoints Explained\" \/>\n<meta property=\"og:description\" content=\"An evidence-led explanation of tirzepatide dual receptor agonism and the endpoints measured in SURPASS and SURMOUNT trials, with clear limits on applying drug data to catalog materials.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/ja\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-27T10:31:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Tirzepatide Dual GIP\\\/GLP-1 Signaling: Mechanism and Trial Endpoints Explained\",\"datePublished\":\"2026-08-27T10:31:11+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\\\/\"},\"wordCount\":369,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints-featured-v2.webp\",\"articleSection\":[\"Evidence Reviews\"],\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\\\/\",\"name\":\"Tirzepatide Dual GIP\\\/GLP-1 Signaling: Mechanism and Trial Endpoints Explained - NHD\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints-featured-v2.webp\",\"datePublished\":\"2026-08-27T10:31:11+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"An evidence-led explanation of tirzepatide dual receptor agonism and the endpoints measured in SURPASS and SURMOUNT trials, with clear limits on applying drug data to catalog materials.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tirzepatide Dual GIP\\\/GLP-1 Signaling: Mechanism and Trial Endpoints Explained\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/ja\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Tirzepatide \u30c7\u30e5\u30a2\u30eb GIP\/GLP-1 \u30b7\u30b0\u30ca\u30ea\u30f3\u30b0: \u30e1\u30ab\u30cb\u30ba\u30e0\u3068\u30c8\u30e9\u30a4\u30a2\u30eb \u30a8\u30f3\u30c9\u30dd\u30a4\u30f3\u30c8\u306e\u8aac\u660e - NHD","description":"\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9\u4e8c\u91cd\u53d7\u5bb9\u4f53\u30a2\u30b4\u30cb\u30ba\u30e0\u3068\u3001SURPASS \u8a66\u9a13\u304a\u3088\u3073 SURMOUNT \u8a66\u9a13\u3067\u6e2c\u5b9a\u3055\u308c\u305f\u30a8\u30f3\u30c9\u30dd\u30a4\u30f3\u30c8\u306b\u3064\u3044\u3066\u306e\u8a3c\u62e0\u306b\u57fa\u3065\u3044\u305f\u8aac\u660e\u3002\u30ab\u30bf\u30ed\u30b0\u8cc7\u6599\u3078\u306e\u533b\u85ac\u54c1\u30c7\u30fc\u30bf\u306e\u9069\u7528\u306b\u306f\u660e\u78ba\u306a\u5236\u9650\u304c\u3042\u308a\u307e\u3059\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/ja\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/","og_locale":"ja_JP","og_type":"article","og_title":"Tirzepatide Dual GIP\/GLP-1 Signaling: Mechanism and Trial Endpoints Explained","og_description":"An evidence-led explanation of tirzepatide dual receptor agonism and the endpoints measured in SURPASS and SURMOUNT trials, with clear limits on applying drug data to catalog materials.","og_url":"https:\/\/nhdbio.com\/ja\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/","og_site_name":"NHD","article_published_time":"2026-08-27T10:31:11+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u57f7\u7b46\u8005":"NHD Technical Team","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Tirzepatide Dual GIP\/GLP-1 Signaling: Mechanism and Trial Endpoints Explained","datePublished":"2026-08-27T10:31:11+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/"},"wordCount":369,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints-featured-v2.webp","articleSection":["Evidence Reviews"],"inLanguage":"ja","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/","url":"https:\/\/nhdbio.com\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/","name":"Tirzepatide \u30c7\u30e5\u30a2\u30eb GIP\/GLP-1 \u30b7\u30b0\u30ca\u30ea\u30f3\u30b0: \u30e1\u30ab\u30cb\u30ba\u30e0\u3068\u30c8\u30e9\u30a4\u30a2\u30eb \u30a8\u30f3\u30c9\u30dd\u30a4\u30f3\u30c8\u306e\u8aac\u660e - NHD","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints-featured-v2.webp","datePublished":"2026-08-27T10:31:11+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9\u4e8c\u91cd\u53d7\u5bb9\u4f53\u30a2\u30b4\u30cb\u30ba\u30e0\u3068\u3001SURPASS \u8a66\u9a13\u304a\u3088\u3073 SURMOUNT \u8a66\u9a13\u3067\u6e2c\u5b9a\u3055\u308c\u305f\u30a8\u30f3\u30c9\u30dd\u30a4\u30f3\u30c8\u306b\u3064\u3044\u3066\u306e\u8a3c\u62e0\u306b\u57fa\u3065\u3044\u305f\u8aac\u660e\u3002\u30ab\u30bf\u30ed\u30b0\u8cc7\u6599\u3078\u306e\u533b\u85ac\u54c1\u30c7\u30fc\u30bf\u306e\u9069\u7528\u306b\u306f\u660e\u78ba\u306a\u5236\u9650\u304c\u3042\u308a\u307e\u3059\u3002","breadcrumb":{"@id":"https:\/\/nhdbio.com\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nhdbio.com\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/tirzepatide-dual-gip-glp-1-mechanism-trial-endpoints\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Tirzepatide Dual GIP\/GLP-1 Signaling: Mechanism and Trial Endpoints Explained"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"\u30da\u30d7\u30c1\u30c9\u539f\u6599\u30fb\u30ab\u30b9\u30bf\u30e0\u30da\u30d7\u30c1\u30c9\u5408\u6210","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"NHD \u30c6\u30af\u30cb\u30ab\u30eb\u30c1\u30fc\u30e0","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"NHD \u6280\u8853\u30c1\u30fc\u30e0\u306f\u3001\u7814\u7a76\u7528\u306e\u30ab\u30bf\u30ed\u30b0\u6587\u66f8\u3068\u8a3c\u62e0\u306e\u6982\u8981\u3092\u7ba1\u7406\u3057\u307e\u3059\u3002\u67fb\u8aad\u6e08\u307f\u306e\u8ad6\u6587\u306f\u3001\u67fb\u8aad\u6e08\u307f\u306e\u8ad6\u6587\u3001\u6cbb\u9a13\u767b\u9332\u304a\u3088\u3073\u898f\u5236\u8a18\u9332\u306b\u30ea\u30f3\u30af\u3057\u3066\u304a\u308a\u3001\u7121\u52b9\u306a\u6240\u898b\u3084\u7814\u7a76\u306e\u9650\u754c\u3092\u4fdd\u6301\u3057\u3001\u30ab\u30bf\u30ed\u30b0\u8cc7\u6599\u304b\u3089\u51fa\u7248\u3055\u308c\u305f\u4ecb\u5165\u3092\u533a\u5225\u3057\u307e\u3059\u3002 AI \u3092\u5229\u7528\u3057\u305f\u88fd\u56f3\u3092\u69cb\u9020\u306b\u4f7f\u7528\u3067\u304d\u307e\u3059\u3002\u30bd\u30fc\u30b9\u30ea\u30f3\u30af\u3068\u8a3c\u62e0\u306e\u5883\u754c\u306f\u8868\u793a\u3055\u308c\u305f\u307e\u307e\u306b\u306a\u308a\u307e\u3059\u3002\u3053\u306e\u7814\u7a76\u306f\u72ec\u7acb\u3057\u305f\u67fb\u8aad\u3084\u533b\u5b66\u7684\u30a2\u30c9\u30d0\u30a4\u30b9\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/ja\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/posts\/447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/comments?post=447"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/posts\/447\/revisions"}],"predecessor-version":[{"id":524,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/posts\/447\/revisions\/524"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/media\/617"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/media?parent=447"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/categories?post=447"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/tags?post=447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}